Showing results (481-490 of 592) with videos related to

Sort By:
Pageof 60
Hormone Research|January 1, 1987
Clinical and endocrinological characterization of two subjects with Reifenstein syndrome associated with qualitative abnormalities of the androgen receptorH U Schweikert, L Weissbach, C Stangenberg, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 1997
Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous systemY D Zhou, M Barnard, H Tian, et al.
Inorganic Chemistry|September 2, 2021
Reactions of 9-Carbene-9-Borafluorene Monoanion and Selenium: Synthesis of Boryl-Substituted Selenides and DiselenidesKelsie E Wentz, Andrew Molino, Lucas A Freeman, et al.
Chemical Communications (Cambridge, England)|November 2, 2021
Lewis acid activation of Weiss' reagents ([PhI(Pyr)2]2+) with boranes and isolation of [PhI(4-DMAP)]2Aseel Bakro, Lachlan Sharp-Bucknall, Tiffany B Poynder, et al.
Inorganic Chemistry|October 19, 2022
Systematic Electronic and Structural Studies of 9-Carbene-9-Borafluorene Monoanions and Transformations into Luminescent Boron SpirocyclesKelsie E Wentz, Andrew Molino, Lucas A Freeman, et al.
Inorganic Chemistry|June 13, 2022
Accessing Boron-Doped Pentaphene Analogues from 12-BoradibenzofluoreneManjur O Akram, John R Tidwell, Jason L Dutton, et al.
Angewandte Chemie (International Ed. in English)|November 27, 2022
Approaching Dianionic Tetraoxadiborecine Macrocycles: 10-Membered Bora-Crown Ethers Incorporating Borafluorenate UnitsKelsie E Wentz, Andrew Molino, Lucas A Freeman, et al.
The Journal of Clinical Investigation|April 1, 1991
Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapyM J McPhaul, M Marcelli, W D Tilley, et al.
Physiological Measurement|January 22, 2011
Bio-magnetic signatures of fetal breathing movementU D Ulusar, J D Wilson, P Murphy, et al.
The Journal of Infectious Diseases|August 19, 2000
Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to diseaseJ D Wilson, N Imami, A Watkins, et al.
Pageof 60